Literature DB >> 2416925

Should women at high risk of neural tube defect have an amniocentesis?

K M Laurence, G Elder, K T Evans, B M Hibbard, M Hoole, C J Roberts.   

Abstract

As part of an investigation into the practical problems of a maternal serum alphafetoprotein (AFP) neural tube defect (NTD) screening programme carried out in Mid Glamorgan, South Wales, between 1977 and 1979, obstetricians were recommended to refer women with high risk pregnancies directly for counselling, high resolution ultrasonography, and amniocentesis without first carrying out serum screening. Out of 15 687 pregnant women one-third attended too late to be screened. A total of 637 was classed as high risk, mostly at greater risk than 1 in 50 because of a previously affected pregnancy or an affected close relative. Compliance with recommended procedure was relatively low as many were screened. There were 10 pregnancies with a recurrence of NTD, of which one was not tested at all, two were not detected (one closed meningocele and one closed iniencephalic), and seven were detected and the pregnancies terminated. All the latter, as well as the iniencephalic, would have been detected from a serum AFP determination and a high resolution ultrasound scan alone. It is concluded that these investigations are sufficient for high risk pregnancies and that amniocentesis is not really cost effective or necessary unless either of these investigations is abnormal. As numbers in this study were small it is suggested that these conclusions should be tested in a larger study.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416925      PMCID: PMC1049506          DOI: 10.1136/jmg.22.6.457

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  9 in total

1.  A family study of major central nervous system malformations in South Wales.

Authors:  C O Carter; P A David; K M Laurence
Journal:  J Med Genet       Date:  1968-06       Impact factor: 6.318

Review 2.  New uncertainties in prenatal screening for neural tube defect.

Authors:  R Harris; A P Read
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-02

3.  The effect of the introduction of prenatal diagnosis on the reproductive history of women at increased risk from neural tube defects.

Authors:  K M Laurence; J Morris
Journal:  Prenat Diagn       Date:  1981-01       Impact factor: 3.050

4.  Screening for neural-tube defects and maternal anxiety.

Authors:  J Fearn; B M Hibbard; K M Laurence; A Roberts; J O Robinson
Journal:  Br J Obstet Gynaecol       Date:  1982-03

5.  The efficacy of a serum screening service for neural-tube defects: the South Wales experience.

Authors:  C J Roberts; B M Hibbard; G H Elder; K T Evans; K M Laurence; A Roberts; J S Woodhead; I B Robertson; M Hoole
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

6.  Diagnostic effectiveness of ultrasound in detection of neural tube defect. The South Wales experience of 2509 scans (1977-1982) in high-risk mothers.

Authors:  C J Roberts; K T Evans; B M Hibbard; K M Laurence; E E Roberts; I B Robertson
Journal:  Lancet       Date:  1983-11-05       Impact factor: 79.321

7.  Precision in estimating gestational age and its influence on sensitivity of alphafetoprotein screening.

Authors:  C J Roberts; B M Hibbard; D R Evans; K T Evans; K M Laurence; M Hoole; E Roberts; W P Ennis
Journal:  Br Med J       Date:  1979-04-14

8.  Can we afford screening for neural tube defects? The South Wales experience.

Authors:  B M Hibbard; C J Roberts; G H Elder; K T Evans; K M Laurence
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-26

9.  Anxiety during a crisis: emotional effects of screening for neural tube defects.

Authors:  J O Robinson; B M Hibbard; K M Laurence
Journal:  J Psychosom Res       Date:  1984       Impact factor: 3.006

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.